Canine Lymphoma Trial at CVS Angel Care Cancer Center
We are in a process developing a new therapy for dogs with lymphoma that harnesses the immune system to destroy its own cancer. With appropriate therapy we are able to not only enhance and improve their quality of life but also extend that life and reduce the need for chemotherapy. This non-invasive, fully-funded study is one in which we take animals that have lymphoma and willing families who are excited about exploring new opportunities...read more.
Nativis Voyager: Groundbreaking & Revolutionary Cancer Treatment
Dr. Ogilvie is directing a ground breaking canine clinical trial using a new and revolutionary non-invasive medical device called Voyager. The Voyager results are remarkable. Rapid and durable tumor response has been seen in many patients, resulting in partial and complete remissions. After one week of treatment, Voyager safely eliminated 90% of one patient's malignant mass tumor... read more.
Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients
Genelux Corporation, a privately-held clinical-stage biopharmaceutical company focused on development and commercialization of best–in-class vaccinia virus based oncolytic viral therapies and companion diagnostics for human cancer patients, today announced the start of a ground-breaking clinical study involving... read more.
Invisible Virus Is Being Evaluated As The Next Generation of Compassionate Cancer Cures
FOXNews journalists caught up CVS Angel Care clinicians, nurses and researchers at California Veterinary Specialists Angel Care Cancer Center to learn how an invisible virus is being evaluated as the next generation of compassionate cancer cures in dogs, cats and people. Angel Care Cancer Center, a separate but allied... read more.
Learn About California Veterinary Specialists
California Veterinary Specialists is a 24-hour specialty and emergency facility committed to excellence in internal medicine, surgery and critical patient care. Our family of specialists, dedicated emergency clinicians, and experienced staff, provide a unique team approach to referral medicine. We work closely with your primary care doctor to provide the very best in continued care of your pet.
MURRIETA, CALIF. — California Veterinary Specialists Angel Care Center (CVS Angel Care) was named March Business of the Month by Assemblywoman Melissa Melendez for the Center’s canine cancer clinical trials using Voyager, a new and revolutionary non-invasive anti-cancer medical device. “We are overjoyed to receive this award from Assemblywoman Melendez for our work to eliminate cancer in pets,” said Dr. Greg Ogilvie, founder of CVS Angel Care. “Voyager has the potential to save hundreds of thousands of lives and has given families of...
In case you missed it, check out last week’s KUSI-TV live segment with Dr. Ogilvie as he discusses cancer treatment for animals.
Dr. Ogilvie is directing a ground breaking canine clinical trial using a new and revolutionary non-invasive medical device called Voyager. "Voyager is just beginning its voyage as we are beginning the process of identifying the cancers its most effective to treat. It seems to have a broad spectrum of efficacy while being quite safe." The Voyager results are remarkable. Rapid and durable tumor response has been seen in many patients, resulting in partial and complete remissions. After one week of treatment, Voyager safely eliminated 90% of one..
Investigators from California Veterinary Specialists empowered by funding from the Special Care Foundation for Companion Animals, has worked with the discovery team led by Dr. Genevieve Hansen to develop a novel therapy for T-cell lymphoma in dogs. The veterinary oncologists and nurses at all three CVS hospitals (Murrieta, Ontario and Carlsbad) executed a series of clinical and basic science trials to document the safety and efficacy of the monoclonal antibody therapy that triggers the immune system to kill the T cell lymphoma cancer cells ...
The investigative FOXNews journalists caught up with the clinicians, nurses and researchers at California Veterinary Specialists Angel Care Cancer Center to learn how an invisible virus is being evaluated as the next generation of compassionate cancer cures in dogs, cats and people. Angel Care Cancer Center, a separate but allied non-profit research organization, the Special Care Foundation for Companion Animals and the San Diego based company Genelux have teamed up to affirm the safety an efficacy of a new cancer killing virus. The therapy
